Wednesday, Apr 27, 2016 @ 11:57am by Khristopher Flack
Emergent BioSolutions has filed a supplemental Biologics License Application with the U.S. Food and Drug Administration to scale up production of its anthrax vaccine BioThrax.
Read More »
Alerts Sign-up